|
Volumn 30, Issue 3, 2006, Pages 277-282
|
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment
|
Author keywords
FLIPI; Follicular lymphoma; IPI; Prognosis
|
Indexed keywords
ALKYLATING AGENT;
ANTHRACYCLINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL FEATURE;
CONTROLLED STUDY;
CORRELATIONAL STUDY;
DRUG USE;
FEMALE;
FOLLICULAR LYMPHOMA;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
SCORING SYSTEM;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTHRACYCLINES;
ANTINEOPLASTIC AGENTS;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LYMPHOMA, FOLLICULAR;
MALE;
MIDDLE AGED;
PROGNOSIS;
RESEARCH DESIGN;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SEVERITY OF ILLNESS INDEX;
|
EID: 30144443373
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/j.leukres.2005.07.006 Document Type: Article |
Times cited : (19)
|
References (9)
|